**Chapter 2**

*Vascular Biology - Selection of Mechanisms and Clinical Applications*

[124] Ranganath SH et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012;**10**:244-258. DOI:

[125] Schmidt-Lucke C et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;**111**:2981-2987. DOI: 10.1161/ CIRCULATIONAHA.104.504340

[126] Smith W. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. results of the multi mechanical embolus removal in cerebral ischemia (Merci) trial, Part I. American Journal of Neuroradiology. 2006;**27**:1177-1182

[127] Ridker PM. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;**103**:1813-1818. DOI:

10.1161/01.CIR.103.13.1813

10.1016/j.stem.2012.02.005

**26**
